Sign In
Buy DXCM
$83.02
+0.360 (+0.436%)
At Close: Aug 06, 2026
Insulet Stock Rises on Report of Dexcom Acquisition Talks
06:29am, Tuesday, 24'th May 2022
A potential deal could be announced in coming weeks, according to a Bloomberg report.
Dexcom Announces Upcoming Conference Presentation
08:00am, Monday, 23'rd May 2022
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Brice Bobzien, Senior Vice President, Finance, will present an update on the company at the Piper Sandler Ophthalmology and
Here's Why You Should Hold on to DexCom (DXCM) Stock Now
12:02pm, Thursday, 19'th May 2022
DexCom (DXCM) continues to benefit from a solid product portfolio and a strong international presence. However, supply constraints remain a woe.
DexCom (DXCM) Q1 Earnings Miss, Revenues Beat Estimates
08:17am, Friday, 29'th Apr 2022
Despite a decline in bottom line, DexCom's (DXCM) first-quarter results benefit from domestic and international revenue growth and solid new customer additions.
Is DexCom Stock a Buy Now?
06:45am, Friday, 29'th Apr 2022
The diabetes market is full of growth potential.
DexCom, Inc. (DXCM) CEO Kevin Sayer on Q1 2022 Results - Earnings Call Transcript
09:24pm, Thursday, 28'th Apr 2022
DexCom, Inc. (NASDAQ:DXCM ) Q1 2022 Earnings Conference Call April 28, 2022 5:30 PM ET Company Participants Sean Christensen - Investor Relations Kevin Sayer - Chairman, President and Chief Executive
DexCom (DXCM) Misses Q1 Earnings Estimates
07:35pm, Thursday, 28'th Apr 2022
DexCom (DXCM) delivered earnings and revenue surprises of -36% and 1.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
05:27pm, Thursday, 28'th Apr 2022
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. has updated its first quarter 2022 earnings call due to technical difficulties with the conference call provider. The conference call will now start at 5:30 p.
It's Not Too Late to Buy These Market-Beating Stocks
10:45am, Saturday, 23'rd Apr 2022
You haven't missed the boat just yet.
DexCom (DXCM) Stock: $560 Stock And Buy Rating
12:09am, Thursday, 21'st Apr 2022
The shares of DexCom, Inc. (NASDAQ: DXCM) have received a $560 price target from BTIG. These are the details.
Is DexCom (DXCM) a Solid Growth Stock? 3 Reasons to Think " Yes "
02:18pm, Tuesday, 19'th Apr 2022
DexCom (DXCM) could produce exceptional returns because of its solid growth attributes.
According To Analysts, These 12 Fast-Rising Stocks Are On The Way Up
06:25pm, Thursday, 14'th Apr 2022
A dozen S&P 500 stocks are up strongly from the market's low this year, including consumer discretionary firms Pool and D.R. Horton plus communications services company Dish Network.
Why DexCom Surged 23.6% in March
12:16pm, Monday, 11'th Apr 2022
The diabetes management company has launched its latest product to be sold in the United Kingdom.
DexCom's (DXCM) Upcoming Launch to Boost Diabetes Management
11:18am, Tuesday, 05'th Apr 2022
DexCom's (DXCM) upcoming launch of Dexcom ONE CGM can help people in the U.K. to manage diabetes.
Customers Love These 3 Healthcare Companies
11:07am, Saturday, 02'nd Apr 2022
Net Promoter Scores can provide insights into customer satisfaction, and possibly lead to market-beating returns.
